Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook

89°
- Newton, NC (28658)
  Today
  
  Some passing clouds. Low 68F. Winds light and variable..
  
  Tonight
  
  Some passing clouds. Low 68F. Winds light and variable.
  
  Updated: September 17, 2026 @ 6:15 pm
- Full Forecast

Site search

Home
News
Sports
Obituaries
Classifieds
- Place an ad
e-Edition
Best of 2026
Archives

Recent Quotes

View Full List

My Watchlist

Create Watchlist

Indicators

Dow Jones Industrial Average

Markets:

Overview

News

Currencies

International

Treasuries

Bausch Health Companies Inc. Common Stock (NY:BHC)

8.760 -0.150 (-1.68%)

Delayed Quote Updated: 9:35 AM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Two Insider Moonshots Rising on Sudden Buying ↗

February 10, 2022

Biotech insiders are among the most important investors to pay close attention to. Here are two that show good signs for the future.

Via InvestorPlace

Jim Cramer Buys The Dip In Salesforce, Marvell And This Health Stock ↗

January 21, 2022

With the markets falling further into correction territory, Jim Cramer decided to start adding to some of the positions in hi...

Via Benzinga

Bausch Health's Eye-Care Spin-Off Entity Files For $100M IPO ↗

January 14, 2022

Bausch & Lomb Corp filed S-1 for its initial public offering, nearly 1.5 years after its parent company, Bausch Health Companies Inc (NYSE: BHC) said it would...

Via Benzinga

The Daily Biotech Pulse: Bausch Files For Eye Health Unit IPO, LumiraDx Antigen Test Can Detect Omicron, Molecular Partners Discloses Fund Stake ↗

January 14, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Corvus Says Chinese Angel Pharma Starts Phase 1/2 Blood Cancer Study Corvus...

Via Benzinga

Unusual Options Activity Insight: Bausch Health Companies ↗

August 06, 2021

Bausch Health Companies (NYSE:BHC) shares experienced unusual...

Via Benzinga

Unusual Options Activity Insight: Bausch Health Companies ↗

August 04, 2021

Bausch Health Companies (NYSE:BHC) shares experienced unusua...

Via Benzinga

Jim Cramer's Top Stocks For 2022: Eli Lilly, Honeywell And More ↗

January 05, 2022

Jim Cramer announced his top stock picks for 2022 Wednesday on CNBC's "Fast Money Halftime Report." The fo...

Via Benzinga

Stock Market Crash Coming? 7 Wall Street Pros Make Their Predictions ↗

December 29, 2021

December is when analysts and banks issue their extensive stock market outlook and winning stocks for the new year.

Via InvestorPlace

BHC Stock: 9 Things to Know as Jim Cramer Buys Bausch Health ↗

December 20, 2021

The Mad Money host announced a new position in Bausch Health amid the spread of the omicron variant. Here's what you should know.

Via InvestorPlace

4 Stocks Insiders Are Buying ↗

December 03, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t...

Via Benzinga

Why Did Bausch Health Shares Plunge Today? ↗

November 02, 2021

Bausch Health Companies Inc (NYSE: BHC) reported Q3 revenues of $2.111 billion, down 1% Y/Y, missing the consensus of $2.66 billion. Excluding the impact of foreign...

Via Benzinga

Bausch Health Companies inc (BHC) Q3 2021 Earnings Call Transcript ↗

November 02, 2021

BHC earnings call for the period ending October 2, 2021.

Via The Motley Fool

Topics Earnings

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO ↗

October 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends Approval Of Merck, Pfizer's Pneumococcal Vaccine...

Via Benzinga

Friday Market Coverage ↗

October 08, 2021

New hiring again failed to rise in Sept., the 2nd month in a row which may be good news because it could delay the Fed tapering.

Via Talk Markets

Topics Economy

Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates ↗

October 01, 2021

Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new...

Via Benzinga

Why Bausch Health Companies Stock Zoomed 8% Higher Today ↗

September 21, 2021

One analyst crunches the numbers to come up with a share price valuation well above current levels.

Via The Motley Fool

NYSE: BHC Shareholder Notice: Investigation over Potential Wrongdoing at Bausch Health Companies Inc. ↗

September 13, 2021

San Diego, CA -- (SBWIRE) -- 09/13/2021 -- An investigation on behalf of investors in Bausch Health Companies Inc. (NYSE: BHC) shares over potential wrongdoing at Bausch Health Companies Inc. was...

Via SBWire

Topics Supply Chain

Bausch Pays $300M For Diabetes Drug Lawsuit: Reuters ↗

September 10, 2021

Reuters reports that Bausch Health Companies Inc (NYSE: BHC) will pay $300 million to settle an antitrust lawsuit related to illegally maintaining a monopoly on...

Via Benzinga

Topics Lawsuit

Bausch Health Companies Inc. (NYSE:BHC) Investor Notice: Investigation over Possible Violations of Securities Laws ↗

August 16, 2021

San Diego, CA -- (SBWIRE) -- 08/16/2021 -- Bausch Health Companies Inc is under investigation over potential securities laws in connection with certain financial statements.

Via SBWire

Topics Supply Chain

Why Bausch Health Companies Is Plunging Today ↗

August 03, 2021

The turnaround isn't happening as fast as investors expected.

Via The Motley Fool

Topics Product Recall

Q2 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios ↗

August 17, 2021

The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and...

Via Benzinga

75 Biggest Movers From Yesterday ↗

August 04, 2021

Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares climbed 68.1% to close at $58.25 on Tuesday after the company announced that the it has received approval for a...

Via Benzinga

Bausch Health Companies inc (BHC) Q2 2021 Earnings Call Transcript ↗

August 03, 2021

BHC earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

48 Stocks Moving In Tuesday's Mid-Day Session ↗

August 03, 2021

Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 64.4% to $7.15 after a Form 4 filing from the company showed 10% shareholder Retail Ecommerce Ventures...

Via Benzinga

Bausch Health Misses On Q2 Sales, Cuts FY21 Outlook, Plans IPO For Medical Aesthetics Business ↗

August 03, 2021

Bausch Health Companies Inc (NYSE: BHC) has reported Q2 revenues of $2.1 billion, +26% Y/Y, and missing the consensus of $2.12 billion. Revenue increased organically by...

Via Benzinga

Topics Initial Public Offering

Earnings Outlook For Bausch Health Companies ↗

August 02, 2021

Bausch Health Companies (NYSE:BHC) releases its next round of earnings this Tuesday, August 03. Here is Benzinga's essential guide to Bausch Health Companies's Q2 earnings report...

Via Benzinga

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗

August 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Unusual Options Activity Insight: Bausch Health Companies ↗

July 28, 2021

Shares of Bausch Health Companies (NYSE:BHC) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $28.94. Sentiment:...

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
e-Edition
Announcements
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Calendar
Email Alerts
Search
Weather

Contact Information

ObserverNewsOnline.com
309 North College Avenue
Newton, NC 28658
Phone: 828-464-0221
Email: admanager@observernewsonline.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Newton, NC (28658)

Today

Tonight

Bausch Health Companies Inc. Common Stock (NY:BHC)

All News about Bausch Health Companies Inc. Common Stock

Sections

Services

Contact Information

Follow Us